Browse medicines, page 39 of 40

Use listed on the medicine record

Fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis

Use listed on the medicine record

Pregnancy with condom or alone

Use listed on the medicine record

Helps prevent sunburn If used with other sun protection measures (see below), helps decrease the risk of skin cancer and early skin aging caused by the sun

Use listed on the medicine record

Pruritus

Use listed on the medicine record

Remission of ulcerative colitis

Use listed on the medicine record

Elevated intraocular pressure

Use listed on the medicine record

Discomfort associated with acute painful musculo skeletal conditions

Use listed on the medicine record

TAGRISSO is a kinase inhibitor indicated for: • adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. ( 1.1 , 2.2 ) • the treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an…

Use listed on the medicine record

The incidence of recurrent vulvovaginal candidiasis

Use listed on the medicine record

Oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug. Cultures and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug. (See CLINICAL PHARMACOLOGY - Susceptibility Test Methods ). Oxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. Oxacillin should not be used in infections caused by organisms susceptible to penicillin G.

Use listed on the medicine record

The topical treatment of the following dermal infections

Use listed on the medicine record

Stop use and ask a doctor if rash occurs. En cas de rougeurs cessez l'utilisationet consultez un medecin. Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. If swallowed, get medical help or contact a Poison Control Center right away. Avertissements À usage externe seulement Ne pas utilisersur une peau abîmée ou des plaies ouvertes Faites attention à vos yeux lorsque vous utilisez ce produit. Nettoyez avec de l’eau. Ne pas laisser à la portée des enfants.

Use listed on the medicine record

Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings

Use listed on the medicine record

Persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment

Use listed on the medicine record

Adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome

Use listed on the medicine record

Acute attacks of hereditary angioedema

Use listed on the medicine record

Bacterial vaginosis

Use listed on the medicine record

The treatment of adult patients with multiple myeloma who have received at least one prior therapy

Use listed on the medicine record

RETEVMO ® is a kinase inhibitor indicated for the treatment of: Adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a rearranged during transfection (RET) gene fusion, as detected by an FDA-approved test ( 1.1 ) Adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, as detected by an FDA-approved test, who require systemic therapy ( 1.2 ) Adult and pediatric patients 2 years of age and older with advanced or metastatic thyroid cancer with a RET gene fusion, as detected by an…

Use listed on the medicine record

KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2) ]. KOSELUGO is a kinase inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). ( 1 )

Use listed on the medicine record

Hyperphenylalaninemia

Use listed on the medicine record

INDICATIONS & USAGE SECTION Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.

Use listed on the medicine record

INDICATION AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.

Use listed on the medicine record

Sodium Iodide I 131 Capsules Diagnostic is indicated for use in adults for: Assessment of thyroid function using radioactive iodine (RAI) uptake test Imaging the thyroid (scintigraphy) Sodium Iodide I 131 Capsules Diagnostic is a radioactive diagnostic agent indicated for the assessment of thyroid function and for thyroid imaging.

Use listed on the medicine record

aids in the removal of phlegm, mucus, or other secretions associated with occasional sore mouth for temporary use in cleansing minor wounds or minor gum inflammation resulting from minor dental procedures, dentures, orthodontic appliances, accidental injury, or other irritations of the mouth and gums for temporary use to cleanse canker sores assist in the removal of foreign material from minor wounds

Use listed on the medicine record

Hyperkalemia

Use listed on the medicine record

Primary axillary hyperhidrosis

Use listed on the medicine record

LUMAKRAS is an inhibitor of the RAS GTPase family indicated for: KRAS G12C-mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) As a single agent, for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy. ( 1.1 ) This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR).

Use listed on the medicine record

: Cleanse skin to remove impurities. 2: Apply appropriate amount post - cleansing. 3: Use before heavy moisturizers or oils for better absorption.

Use listed on the medicine record

Sulfacetamide Sodium Ophthalmic Solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species. Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa .

Use listed on the medicine record

Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Limitations of Use: Use only if a clear diagnosis of migraine or cluster headache has been established. If a patient has no response to the first migraine or cluster headache attack treated with sumatriptan injection, reconsider the diagnosis before sumatriptan injection is administered to treat any subsequent attacks. Sumatriptan injection is not indicated for the prevention of migraine or cluster headache attacks.

Use listed on the medicine record

The cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis

Use listed on the medicine record

Deleterious or suspected deleterious germline BRCA -mutated (g BRCA m) HER2-negative locally advanced or metastatic breast cancer

Use listed on the medicine record

Locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) [see Dosage and Administration ( 2

Use listed on the medicine record

Appendicitis (complicated by rupture or abscess) and peritonitis caused by beta-lactamase producing isolates of Escherichia coli or the foll